Chronic Obstructive Pulmonary Disease (COPD) in the U.S.
- Detailed references
- Editorially prepared
- Download as PDF / PPT
Prevalence of COPD among U.S. adults as of 2017, by smoking status
Prevalence of COPD among U.S. adults as of 2017, by smoking status and gender
Prevalence of COPD among U.S. adults as of 2017, by smoking status and age
Prevalence of COPD among U.S. adults as of 2017, by smoking status and ethnicity
COPD among U.S. adults as of 2017, by smoking status and urban-rural status
COPD prevalence in the U.S. 2017, by state
COPD prevalence among former smokers in the U.S. 2017, by state
COPD prevalence among current smokers in the U.S. 2017, by state
Prevalence of COPD among employed non-smokers in the U.S. 2013-2017, by gender
Prevalence of COPD among employed non-smokers in the U.S. from 2013-2017, by age
Prevalence of COPD among employed non-smokers U.S. 2013-2017, by ethnicity
Prevalence of COPD among employed non-smokers U.S. 2013-2017, by region
Prevalence of COPD among employed non-smokers U.S. 2013-2017, by industry
Prevalence of COPD among employed non-smokers U.S. 2013-2017 by occupation
COPD prevalence among non-smokers in the U.S. 2017, by state
Leading causes of death in the United States 2020
Rates of the leading causes of death in the U.S. 2020
COPD death rate among U.S. adults from 2000 to 2014, by gender
COPD death rate among U.S. adults from 2000 to 2014, by ethnicity
COPD death rate among older U.S. adults in 2014, by age and gender
COPD death rate in the U.S. 2015, by urban-rural status
Leading underlying causes of death among COPD deaths in the U.S. in 2014, by gender
Number of adult smokers in the United States 1965-2020
U.S. smoking prevalence among adults by ethnicity 2019
Percentage of adults in the U.S. who smoke as of 2020, by state
U.S. adult tobacco product use in 2020, by age
Exacerbation in the past year among those with COPD in the U.S. as of 2020
Symptoms experienced by individuals in the U.S. with COPD in 2020
Comorbidities experienced among U.S. adults with COPD as of 2019
Tests commonly used for diagnosing COPD in the U.S. 2018
Treatments and alternative therapies used by those with COPD in the U.S. as of 2018
U.S. aggregate costs of potentially preventable inpatient stays in 2017, by condition
U.S. mean cost per stay of potentially preventable inpatient stays 2017, by condition
Asthma/COPD drug PMPM spending U.S. 2019-2024
Mon - Fri, 9am - 6pm, EST
Mon - Fri, 9:30am - 5pm, GMT
Choose one of our Corporate Solutions to get full access to our international database.